New guidelines from the NCCN for polycythemia vera

Clin Adv Hematol Oncol. 2017 Nov;15(11):848-850.
No abstract available

Publication types

  • Interview

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Cytoreduction Surgical Procedures
  • Disease Management
  • Humans
  • Hydroxyurea / therapeutic use
  • Polycythemia Vera / complications
  • Polycythemia Vera / diagnosis
  • Polycythemia Vera / therapy*
  • Pyrazoles / therapeutic use
  • Thrombosis / prevention & control

Substances

  • Antineoplastic Agents
  • INCB018424
  • Pyrazoles
  • Hydroxyurea